![Richard C. Schmitt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard C. Schmitt
Directeur/Membre du Conseil chez EpiWatch, Inc.
Postes actifs de Richard C. Schmitt
Sociétés | Poste | Début | Fin |
---|---|---|---|
EpiWatch, Inc.
![]() EpiWatch, Inc. Internet Software/ServicesTechnology Services EpiWatch, Inc. is a company founded by Nathan Crone and Gregory professors of neurology and epileptologists at the Johns Hopkins School of Medicine. The company is based in Baltimore, MD and uses technology licensed from Johns Hopkins. EpiWatch aims to lead the digital transformation of epilepsy care by delivering innovative and integrated services that keep people with epilepsy safe, enable them, their caregivers, and their physicians to better manage their condition, and provide peace of mind for their loved ones. The company is initially developing a proprietary capability to detect and alert for potentially dangerous tonic-clonic (grand mal) seizures. EpiWatch is leading the digital transformation of epilepsy care by delivering innovative and integrated services that keep people with epilepsy safe, enable them, their caregivers, and their physicians to better manage their condition. Dean Papadopoulos has been the CEO of the company since 2020. | Directeur/Membre du Conseil | 07/04/2022 | - |
Historique de carrière de Richard C. Schmitt
Formation de Richard C. Schmitt
Tuck School of Business at Dartmouth | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Director/Board Member | 1 |
Masters Business Admin | 1 |
Sectorielle
Technology Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
EpiWatch, Inc.
![]() EpiWatch, Inc. Internet Software/ServicesTechnology Services EpiWatch, Inc. is a company founded by Nathan Crone and Gregory professors of neurology and epileptologists at the Johns Hopkins School of Medicine. The company is based in Baltimore, MD and uses technology licensed from Johns Hopkins. EpiWatch aims to lead the digital transformation of epilepsy care by delivering innovative and integrated services that keep people with epilepsy safe, enable them, their caregivers, and their physicians to better manage their condition, and provide peace of mind for their loved ones. The company is initially developing a proprietary capability to detect and alert for potentially dangerous tonic-clonic (grand mal) seizures. EpiWatch is leading the digital transformation of epilepsy care by delivering innovative and integrated services that keep people with epilepsy safe, enable them, their caregivers, and their physicians to better manage their condition. Dean Papadopoulos has been the CEO of the company since 2020. | Technology Services |
- Bourse
- Insiders
- Richard C. Schmitt
- Expérience